Saentra Forge (SAEN) AI Stock Analysis

78 Followers

Saentra Forge

(NASDAQ:SAEN)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Negative Factors

Saentra Forge (SAEN) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $32.79M
Dividend Yield: ―
Average Volume (3M): 85.32K
Price to Earnings (P/E): -1.9
Beta (1Y): 0.40
Revenue Growth: ―
EPS Growth: 29.62%
Country: US
Employees: 9
Sector: Healthcare
Sector Strength: 51
Industry: Conglomerates

Saentra Forge Business Overview & Revenue Model

Company Description

Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, n...

Saentra Forge Risk Analysis

Saentra Forge disclosed 91 risk factors in its most recent earnings report. Saentra Forge reported the most risks in the "Tech & Innovation" category.

Tech & Innovation - Risks related to the company’s reliance on technology and ability to make innovative products

Latest Risks Added

3 New Risks

1.The proposed loyalty share program could have a negative effect on the liquidity of our ADSs and may make it more difficult for investors to acquire a controlling interest, change the management or the strategy of our company or exercise influence over us, which may adversely affect the market price of the ADSs. Further, the proposed loyalty share program would be available only to holders who own their ordinary shares in registered form, and the ability of ADS holders to influence corporate decisions may therefore be limited.Q4, 2023

2.Clinical drug development involves a lengthy and expensive process with uncertain timelines and uncertain outcomes, and results of earlier trials may not be predictive of future trial results. If clinical studies of our product candidates are prolonged or delayed, we may be unable to obtain the required regulatory approvals, and therefore be unable to commercialize our product candidates on a timely basis or at all.Q4, 2023

3.There is a substantial risk that we are or will become classified as a passive foreign investment company. If we are or become classified as a passive foreign investment company, our U.S. shareholders may suffer adverse tax consequences as a result.Q4, 2023

Saentra Forge Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

SAEN against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ACRV	52Neutral	$67.28M	-0.83	-70.14%	―	―	16.04%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
VERU	44Neutral	$36.15M	-3.56	-45.89%	―	-100.00%	68.62%
ALGS	40Underperform	$18.11M	-0.34	-206.30%	―	1171.58%	49.20%
ANL	39Underperform	$641.40M	-5.55	-21.82%	―	―	―
CUE	34Underperform	$136.28M	-0.69	-1032.19%	―	354.37%	-63.33%

* Healthcare Sector Average

Performance Comparison

SAEN and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
SAEN	Saentra Forge	0.68	-1.50	-68.81%
VERU	Veru Inc	2.14	-0.37	-14.74%
CUE	Cue Biopharma	18.66	0.07	0.39%
ALGS	Aligos Therapeutics, Inc.	2.16	-3.91	-64.42%
ACRV	Acrivon Therapeutics, Inc.	1.57	-0.50	-24.15%
ANL	Adlai Nortye Ltd. Sponsored ADR	10.85	9.34	618.54%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Saentra Forge AI Stock Analysis